In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More
2 years ago
6
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) and BIV201 for Refractory Ascites and HRS-AKI. Visit https://bit.ly/BioVie to learn more.
Loading comments...
-
16:48
MetatronGaming
5 days agoI bought a 1998 Vintage Computer and turned it on after 27 years!
2584 -
LIVE
This is the Ray Gaming
40 minutes agoHappy Black Fri-RAY | Rumble Premium Creator
113 watching -
1:03:47
The Mike Schwartz Show
14 hours agoTHE MIKE SCHWARTZ SHOW with DR. MICHAEL J SCHWARTZ 11-28-2025
4.01K4 -
7:02
DEADBUGsays
4 hours agoThe Murder of Kathy Halle | Solved #19
1.79K2 -
56:09
A Cigar Hustlers Podcast Every Day
6 hours agoCigar Hustlers Podcast Every Week Day "Holiday Travel, Black Friday"
4.04K -
24:56
Jasmin Laine
19 hours agoOttawa Uses CHILDREN to Push Censorship—Carney Tears Up His Own Climate Agenda
32.1K41 -
12:45
MudandMunitions
18 hours agoSupercharged Silverado Trail Boss Lifted 35s & Steelcraft Bumper
22.8K7 -
8:25
Hollywood Exposed
15 hours agoRob Schneider DESTROYS De Niro After His Anti-Trump Meltdown
19.5K65 -
1:43
GreenMan Studio
17 hours agoWEAK MEN W/Greenman Reports
24.4K7 -
2:05:28
BEK TV
2 days agoTrent Loos in the Morning - 11/28/2025
17.5K